U.S. Digital Ovulation Test Kits Market over the forecast period, generating a revenue of US$ 95.1 Million by 2031

Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most fertile days of their menstrual cycle by measuring the changes in the level of luteinizing hormone (LH), which is important to fertility parameters. According to Future Market Insights (FMI) the U.S. digital ovulation test kits market is estimated to be US$ 80 Mn in 2021, and is expected to grow at a market CAGR of 9.6% during the forecast period (2021-2031)

Some of the digital devices available in the market have advanced features such as connectivity to Bluetooth or smart countdown. Clearblue, First Response and E.P.T. are some of the most popular digital ovulation test kits brands available in the U.S. market.

Increasing purchasing power and growing consumer awareness about women’s health are the two factors expected to drive the growth of the digital ovulation test kits market in the U.S. Various states in the country are focusing on improving women health through various awareness and healthcare programs.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

For instance, the American pregnancy association along with its education partner Fairhaven Health LLC guides ovulation testing to couples trying to get pregnant. This is anticipated to boost the growth of the digital ovulation test kit market.

Rising first-time pregnancy demographics and decreasing fertility rates, along with rising levels of disposable income and growing advancements in ovulation testing are some of the major factors driving the growth of the digital ovulation test kit market in the U.S.

The COVID-19 pandemic has significantly affected the sale of digital ovulation test kits. The nationwide lockdown and disrupted supply chains have limited the availability of these products. The pandemic in the first few months of 2020 has negatively impacted the digital ovulation test kits market.

Key Takeaways from the U.S. Digital Ovulation Test Kits Market Study

  • Branded test kits are expected to dominate the U.S. digital ovulation test kits market, rising at a CAGR of around 9.3%.
  • Institutional sales are expected to witness significant growth with easier access to patients driving a CAGR of around 8.8%.
  • Home based use of digital ovulation test kits to gain traction owing to lower stress for use through menstrual cycles.
  • Relatively higher costs to potentially limit sales of digital variants of ovulation test kits in the country.

“Increasing consumer awareness about fertility monitoring parameters, along with high cost and low accuracy associated with fertility treatments are expected to aid the demand for digital ovulation test kits in the U.S. through the end of the forecast period in 2031,” says the FMI Analyst

Who is Winning?The U.S. market is set to expand strongly owing to the rising prevalence of fertility disorders and the adoption of digital ovulation test kits. Furthermore, the advancements in digital ovulation test kits are expected to boost market demand.

Manufacturers are currently focusing on designing novel offerings that can provide better results at a lower cost, while also providing simple and reliable outputs. Key manufacturers are signing strategic partnership agreement within the industry to expand their product portfolios across the U.S.

  • In 2017, Sugentech, a major digital ovulation test kits manufacturer entered into a strategic partnership with CGETC, Inc., a consumer fulfilment and marketing company located in the U.S.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13241

The business alliance aims to support the distribution of product portfolios across the country and emerging players are extending their partnership to strengthen their market presence.

  • For instance, In February 2019 NFI Consumer Healthcare expanded the agreement with Callitas Health to distribute co-branded products such as NFI’s e.p.t, the leading Over-the-Counter (OTC) ovulation test kit in the U.S.

Key market players covered by FMI include Church & Dwight Co. Inc., Swiss Precision Diagnostics GmbH, Sugentech Inc., Gregory Pharmaceutical Holdings, Inc., iXensor Co. Ltd, Samplytics Technologies Private Limited, Bio-AMD, and others consolidating their positions through mergers, acquisitions and new product launches.

Want more Insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The U.S. digital ovulation test kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on digital ovulation test kits market on basis of product in detail, cover every aspect of the market such as (Branded Test Kits and Private Label Test Kits), and distribution channel (Institutional Sales (Hospital Pharmacies, Gynecology Clinics, IVF Clinics and Maternity Care Centers) and Retail Sales (Retail Pharmacies, Drug Stores, Hypermarkets & Supermarkets and Online Sales)) in the U.S.

Digital Ovulation Test Kits Market by CategoryBy Product:

  • Branded Test Kits
  • Private Label Test Kits

By Distribution Channel:

  • Institutional Sales
    • Hospital Pharmacies
    • Gynaecology Clinics
    • IVF Clinics
    • Maternity Care Centers

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13241

  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Hypermarkets & Supermarkets
    • Online Sales

Industrial and Institutional Cleaning Chemicals Market is expected to increase at a CAGR of 5.2% over the forecast period 2016–2026

Future Market Insights delivers key insights on the global industrial and institutional cleaning chemicals market in its latest report titled ‘Industrial and Institutional Cleaning Chemicals Market: Global Industry Analysis and Opportunity Assessment, 2016-2026’.

Global sales revenue of industrial and institutional cleaning chemicals is projected to be valued at US$ 40.13 Bn by 2016, witnessing a Y-o-Y growth of 3.9% over 2015. The APEJ regional market is expected to register high growth followed by the Latin America industrial and institutional cleaning chemicals market.

The modern healthcare sector uses various devices and procedures to treat patients. The devices used in medical procedures are prone to serious infections. With the number of patients increasing in hospitals, the associated healthcare infections have emerged as a severe health issue in the past few years, posing a big threat to patient safety. It is estimated that over 20%-30% of these healthcare related infections can be prevented by intensive hygiene and control programs. Moreover, National Action Plan to Prevent Health Care-Associated Infections set by the U.S. Department of Health and Human Services (HHS) is also focussing on decreasing the number of such infections by 2020. Thus, due to continuation of promotional campaigns designed to increase awareness among consumers regarding the advantages of cleaning products, the cleaning chemicals demand is projected to increase over the projected period.

Demand for meat products is increasing, mainly due to the rapid growth in population, westernisation of economies and changing food preferences. This increasing demand, in turn, is likely to lead to a rise in cold storage capacities and the need for a high level of hygiene. Combination of all these factors is projected to drive the consumption of industrial and institutional cleaning chemicals during the assessed period.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1088

Segmentation highlights

Based on a primary source, the global industrial and institutional cleaning chemicals market can be segmented by application as commercial, Industrial and domestic. Industrial application is further classified as hand hygiene chemicals, building care chemicals, and others. The Commercial and domestic application segments are further bifurcated as laundry care chemicals, building care chemicals, kitchen care chemicals, hand hygiene chemicals, and others. Each sub-segment can be further categorised based on chemicals as citric acid, lactic acid, formic acid, phosphoric acid, acetic acid, hydrochloric acid, chlor alkalis, surfactants, chelating agents, phosphates, biocides, and solvents.

  • The commercial segment will hold significant share in the global industrial and institutional cleaning chemicals market, registering a significantly high CAGR in terms of value during the period of assessment. The segment is estimated to create incremental opportunity of US$ 12.33 Bn during projected period.
  • Laundry care chemicals sub-segment in industrial application segment is estimated to exhibit a CAGR of 5.9% in terms of value during the studied period. The segment is anticipated to create incremental opportunity of US$ 5,052.6 Mn which is approximately 34% of the total incremental opportunity.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1088

Regional market projections

The global industrial and institutional cleaning chemicals market is segmented on the basis of region as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (excluding Japan), Japan and Middle East and Africa. APEJ is expected to register relatively high CAGR in terms of value during the assessed period. China and India are highly focussed on increasing hygiene awareness. Western Europe and North America are estimated to collectively account for a share of market value of over 51.5% by 2016 end.

Vendor insights

The major companies in the industrial and institutional cleaning chemicals market include Procter & Gamble Co., Huntsman Corporation, The Dow Chemical Company, BASF SE, Akzo Nobel N.V., Lonza Group Limited, Henkel AG & Co. KGaA, Betco Corporation, Solvay SA, Eastman Chemical Companyand Croda International Plc. These players have adopted a strategy of increasing their production capacities across the world.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-1088

Market segmentation

To understand and assess opportunities in the global industrial and institutional cleaning chemicals market, we have bifurcated the report into two sections based on market segmentation as under:

By Application

  • Industrial
  • Commercial
  • Domestic

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Middle East & Africa (MEA)
  • Japan

Refrigeration Oil Market is expected to increase at a CAGR of 5.3% over the forecast period 2016–2026

Future Market Insights delivers key perceptions on the global refrigeration oil market in its latest report titled ‘Refrigeration oil Market: Global Industry Analysis and Opportunity Assessment, 2016–2026’.

Global sales of refrigeration oil were estimated to be valued at US$ 1,026.8 Mn in 2015, and is anticipated to increase with a CAGR of 5.3% over the forecast period. Asia Pacific Excluding Japan is estimated to account for the regional share of 31.2% in the global refrigeration oil market by the end of 2016 and is expected to retain its dominance throughout the forecast period.

Refrigeration oil is a lubricant, derived from either mineral oil or synthetic oil which is a blend of a special high-temperature formulation of oils and additives in order to provide lubrication to compressors. The refrigeration oil flows under pressure where it changes its state from liquid to vapours for generation of the cooling effect. Some of the major reasons for the rise in demand for refrigeration oil in compressors as a lubricant is the cold chain transportation for frozen food, beverages and meat products, HVAC&R systems in healthcare sectors and increasing preferences towards low GWP refrigerants.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-870

Consumption of electricity power more than 70% by the refrigeration equipment and the depletion of ozone layer due to increasing emission of Green House Gases (GHG) from refrigeration systems has led to the production and adoption of low GWP refrigerants which will boost demand for more energy efficient  refrigeration oil. Various government organisations are trying to enforce amendments over the industries to reduce the use of HCFCs and CFCs in refrigeration system until 2030 by A5 countries in order to identify such refrigerants as obsolete. Thus, adoption of new refrigerants is expected to be the major reason behind the development of refrigeration oil compatible with these refrigerants in refrigeration.

Segmentation highlights

  • Based on product type, the global refrigeration oil market can be segmented into mineral oil and synthetic oil. The synthetic oil segment is expected to hold a significant share in the global refrigeration oil market and is expected to expand relatively higher in terms of value over the forecast period. The segment is expected to create incremental opportunity more than the mineral oil segment during 2016–2026
  • Based on the refrigerant type the global refrigeration oil market can be segmented as chlorofluorocarbon (CFC), hydro-chlorofluorocarbon (HCFC), hydro-fluorocarbon (HFC), ammonia and others. The growth rate of the others segment is expected to accelerate as compared to remaining refrigerants in terms of value and is anticipated to create a productive incremental opportunity over the forecast period
  • Based on application the global refrigeration oil market can be segmented as air conditioners, coolers, chillers, refrigerators/ freezers, condensers and others. The air conditioners segment is estimated to account for a major share in the overall global refrigeration oil market with relatively maximum CAGR value over the forecast period
  • Based on end user the global refrigeration oil market can be segmented as industrial, commercial and residential. Industrial segment is estimated to be a major contributor in the overall global refrigeration oil market followed by commercial and residential sectors by 2026 end 

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-870

Regional market projections

The global refrigeration oil market is segmented on the basis of region into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa. APEJ is anticipated to register the highest CAGR in terms of value over the forecast period. North America and Europe are highly focussed on using low GWP refrigerants in refrigeration oil. The markets of Latin America, Middle East & Africa and Japan are expected to remain stagnant over the forecast period.

Vendor insights

The major shareholders of the global refrigeration oil market are MEIWA CORPORATION, Royal Dutch Shell plc, ExxonMobil Corporation, Idemitsu Kosan Co. Ltd, FUCHS Lubricants, Chevron Phillips Chemical Company, BASF SE and The Lubrizol Corporation. These players have adopted a strategy of capacity expansion of their existing production units and strengthening the sales distribution networks worldwide to meet the increasing demand for refrigeration oil across the globe and are therefore expected to offer productive market opportunity over the forecast period.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-870

Global refrigeration oil market segmentation

By Product Type

  • Mineral Oil
  • Synthetic Oil

By Refrigerant Type

  • Chlorofluorocarbon (CFC)
  • Hydro-chlorofluorocarbon (HCFC)
  • Hydro-fluorocarbon(HFC)
  • Ammonia
  • Others

By Application

  • Air Conditioners
  • Coolers
  • Chillers
  • Refrigerators/Freezers
  • Condensers
  • Others (Ice Machines etc).

Grignard Reagents Market is expected to increase at a CAGR of 4.2% over the forecast period 2016–2026

As per a newly tabled report published by Future Market Insights titled “Grignard Reagents Market: NAFTA and Europe Industry Analysis and Opportunity Assessment-2016-2026”, the total worth of the Grignard Reagents market is anticipated to touch a whopping value of US$ 2.8 Bn by the end of the year 2016. The market will surge at a standard CAGR of 4.2% during the forecast period (2016-2026). Though the catalyst and the stabilisers application segments dominated the Grignard Reagents market in 2015, this report suggests a steep rise in the others segment in the coming years. This fragment of the market is expected to climb the ladder at a CAGR of 3.5% within the prediction period.

The fabric of the Grignard Reagents market is changing fast.  The new innovative, eco-friendly nature is enhancing its market acceptance and creating a new room for growth. The global boom in the pharmaceutical industry and a swell in the population of breast cancer patients is also favouring the market expansion of Grignard based chemicals. The adaptive and versatile nature of Grignard Reagents are also giving a proper face-lift to this niche market. The shipment of the chemicals is done with utmost care as they are highly reactive.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-NA-2357

Segmentation analysis

The Future Market Insights market review on the Grignard Reagents market unleashes several new unknown aspects of the steadily dilating market. It’s a smart and crisp comprehensive study of the Grignard Reagents market across the regions of NAFTA and Europe. The report gauges the market potential and also unveils the scope of growth for the Grignard Reagents market in the coming decade.

  • Nature friendly feature of Grignard Reagents will help expedite market expansion within the forecast period
  • The market is dissected into three application categories – Stabilisers, Catalyst and Others. Amongst the three the Others segment will showcase a promising CAGR growth of 3.5% within the forecast period of 2016-2026
  • Agrochemicals and Flavour and Fragrances segments are expected to hold 27.8% of the total market share by the end of 2016
  • The Research end user segment will swell at a value CAGR of 3.8% by the end of 2026

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-NA-2357

Regional analysis

The Grignard Reagents market has grown significantly in the NAFTA and Europe regions. The market insight reveals that the Grignard Reagents market will swing out better results from the NAFTA region in the forthcoming years. The market of this region will expand manifold within the forecast period and it will witness a CAGR of 4.5%. The market will mature and the total value of the Grignard Reagents market will touch US$ 2.3 Bn by the end of the forecast period in the NAFTA region. The pharmaceutical industry is clawing into the NAFTA region rapidly and a huge influx of funds is broadening the scope of the Grignard Reagents market in this region. The markets spread across the European region are expected to garner this growth. Future Market Insights analysts predict that the market will expand at a CAGR of 3.9% by 2026.

Vendor insights

The constant rise of the use of Grignard Reagents in the pharmaceutical sector is positively impacting the Y-O-Y growth of the market. Grignard Reagents are widely used in novel drugs, cough medicines, pain relief drugs, flavours and fragrances and for making crop protecting chemicals.  Some of the leading manufacturers of this materials are mobilising the market for Grignard Reagents. Albemarle Corporation, GFS Chemicals, FMC Corp., WeylChem GmbH, SABIC, Rieke Metal LLC. Pentagon Chemicals, Thermo Fischer Scientific, Boulder Scientific Company are some of the key players in the market. These major stakeholders of the market are depending on strong marketing and distribution channels to ensure rapid growth. Apart from this, significant mergers and cross-continental collaborations are further fuelling the growth of the Grignard Reagents market.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-NA-2357

Market segmentation

By Application

  • Catalyst
  • Stabilisers
  • Others

By End User

  • Pharmaceuticals
  • Agrochemicals
  • Flavours and Fragrances
  • Packaging
  • Research

By Region

  • NAFTA (US, Canada, and Mexico)
  • Europe (Germany, France, U.K, Spain, Italy, Russia,
  • Rest of Europe )

Polyunsaturated Fatty Acids (PUFAs) Market is expected to witness a CAGR of 10.7% over the forecast period 2016–2026

In this report, Future Market Insights (FMI) delivers key insights on the global polyunsaturated fatty acids (PUFAs) market in its published report, titled “Global Polyunsaturated Fatty Acids (PUFAs) Market: Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global polyunsaturated fatty acids (PUFAs) market is estimated to register a promising 10.7% CAGR between 2016 and 2026, owing to numerous factors, about which FMI offers thorough insights and forecasts in this report.

The prime factors fuelling the demand for PUFAs are rising occurrence of diseases such as such as cancer, cardiovascular diseases, and diabetes, and growing preference for PUFAs (mono & poly-unsaturated fats). Furthermore, a growing use of PUFAs as an ingredient of choice in processed and convenience food is fuelling the intake of PUFAs all over the world. Additionally, a growing adoption of PUFAs in dietary supplements for children is expected to propel the demand for PUFAs.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2326

Segmentation analysis

  • The global polyunsaturated fatty acids (PUFAs) market is segmented by product type, source, form, and application. Among all the product type segment, the omega-3 fatty acids segment is expected to exhibit the highest revenue growth, followed by the omega-6 fatty acids segment over the forecast period. The omega-3 fatty acids product type segment is anticipated to register a significant CAGR of 11.0% through 2026.
  • To provide in-depth insights on the pattern of demand for polyunsaturated fatty acids (PUFAs), the market has been segmented into sources such as marine and plant. The marine source segment is projected to exhibit a significant value CAGR of 11.3%. The marine source segment is further divided into algal and fungus oil, fish oil, and krill oil.
  • The fish and krill oil segments are collectively expected to contribute significantly in the growth of marine segment. The plant source segment is further differentiated into chia seed oil, flax seed oil and other (hemp, canola oil, sunflower oil, soybean oil, primrose oil and camelina oil). The chia seed oil and other (includes sunflower, canola and soybean oil) segments are expected to collectively contribute in the growth of plant source segment.
  • The market has also been segmented by form into oil, syrup, softgel and capsule, and other (powder, emulsion and gummy candy) segments. Increasing consumption of oil segment is likely to be highest during the forecast period, with the segment registering a 11.3% CAGR.
  • On the basis application, the market is categorised into dietary supplement, infant formula, pharmaceuticals, food and beverages, and animal food and feed. The dietary supplement segment will continue dominance over other segments by attaining a highest market share of 46.0 % in 2016.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-2326

Regional analysis

On the basis of region, The Western Europe market has been estimated to lead the global polyunsaturated fatty acids (PUFAs) market, accounting for maximum revenue share of the market by 2016 end. Collectively, Western Europe and North America markets are expected to account for over 50.4% revenue share of the global polyunsaturated fatty acids (PUFAs) market by 2016 end. Owing to increasing seafood consumption and production, the Eastern Europe PUFAs market is projected to exhibit decent CAGR of 11.0% between 2016 and 2026. The APEJ PUFAs market is estimated to witness a comparatively high CAGR of 14.1% through 2026. The Japan regional market is likely to register a CAGR of 10.1% while Latin America and MEA are expected to grow at a modest rate in the global polyunsaturated fatty acids (PUFAs) market over the next 10 years.

Vendor insights

A few of the top companies in the global polyunsaturated fatty acids (PUFAs) market include Koninklijke DSM N.V., BASF SE, Croda International PLC, Enzymotec Ltd., Omega Protein Corporation, Aker BioMarine AS, Polaris Nutritional Lipids, FMC Corporation, Cargill, Incorporated, GlaxoSmithKline plc

In this report, Future Market Insights has discussed individual strategies followed by these companies in terms of enhancing their product portfolio, creating new marketing techniques, mergers and acquisitions. The ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and company share collectively.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-2326

Global polyunsaturated fatty acids (PUFAs) market segmentation

By Product Type

  • Omega-3 Fatty Acids
  • Omega-6 Fatty Acids

By Source

  • Marine
  • Plant

By Form

  • Oil
  • Syrup
  • Softgel and Capsule
  • Other (Powder, Emulsion and Gummy Candy)

By Application

  • Dietary Supplement
  • Infant Formula
  • Pharmaceuticals
  • Food and Beverages
  • Animal Food and Feed

U.S.Lime Market is estimated to register a value CAGR of 3.7% during the forecast period 2016–2026

Future Market Insights presents an analysis of the U.S lime market in a new publication titled “Lime Market: U.S. Industry Analysis and Opportunity Assessment, 2016–2026.” The consumption of lime in the U.S. was pegged at 19,600 KT in 2015 and this is expected to increase to 27,074 KT by the end of 2026. The U. S lime market is projected to represent incremental $ opportunity of US$ 1,096.8 Mn during 2016 – 2026. In this report, Future Market Insights throws light on the various drivers and restraints likely to influence the market during the forecast period (2016 – 2026).

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-US-2209

Segmentation highlights

The U.S lime market is segmented on the basis of Product Type into Quick Lime and Hydrated Lime; and on the basis of Application into Cement Manufacturing, Metal Manufacturing, Chemical (Water Treatment, Flue Gas, Others), Fertilizer, Pulp & Paper, and Others.

  • The Quick Lime product type segment is expected to account for a market value share of 83.3% by 2016 end and is expected to gain 90 BPS over the forecast period
  • The Hydrated Lime product type segment is projected to account for a market value share of 16.7% by 2016 end and is estimated to be pegged at 2,967 KT in terms of volume by 2016 end
  • The Metal Manufacturing application segment is anticipated to account for a market value share of 32.8% by 2016 end and is estimated to be pegged at 6,614 KT in terms of volume by 2016 end
  • The Chemical application segment is likely to account for a market value share of 33.3% by 2016 end and is anticipated to be pegged at 6,724 KT in terms of volume by 2016 end

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-US-2209

Regional projections

The U.S lime market is segmented into the key regions of Northeast, Midwest, South, and Western. The Northeast U.S. lime market is estimated to account for a value share of 7.1% of the U.S lime market by 2016 end. Demand for lime in the Northeast U.S lime market is expected to be driven by water treatment plants. The Western U.S. lime market is estimated to account for a market value share of 16.7% by 2016 end, owing to an increasing production in the paper and pulp manufacturing industries.

Vendor insights

The report profiles a few leading companies operating in the U.S lime market such as Mississippi Lime Company, Linwood Mining & Minerals Corporation, United States Lime & Minerals Inc., Lhoist, Valley Minerals LLC., CHENEY LIME & CEMENT COMPANY, Pete Lien & Sons Inc., CARMEUSE, and Graymont Limited. Top market players are increasing their production facilities and introducing advanced technology and tools to cater to market demands, besides adopting strategies such as acquisitions and partnerships to expand geographically and increase market share.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-US-2209

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Stereotactic Planning Software Spending Analysis Market valuation is expected to reach US$ 128.2 Million by 2031

Stereotactic planning software is an interactive software tool used in stereotactic planning applications of recording chamber placement and electrode trajectories. It combines basic trajectory planning to obtain arc settings with advanced planning capabilities that improve O.R. workflows, localization of functional areas, and deep brain stimulation (DBS). According to the recent Future Market Insights (FMI) report, the global stereotactic planning software spending analysis is estimated to be US$ 252.6 Mn in 2021, with a market CAGR of 4.6% during the forecast period (2021-2031).

The high prevalence of neurological disorders and small cell lung cancer is expected to boost the demand in the stereotactic planning software market. For instance, Parkinson’s disease and other movement disorders are estimated to affect 2.75 million people in the United States. According to DALY’s, in the U.S., stroke accounts for 3.58 Mn people, Alzheimer’s disease for 2.55 Mn, and migraine for 2.4 Mn.

Furthermore, increasing investments in better treatment options involving precision and artificial intelligence in the software provide impetus to the market by increasing the overall adoption rate. Patients are inclined towards safer and better treatment facilities with minimal incision. Stereotactic planning software facilitates surgeons to plan stereotactic surgery efficiently.

However, the unprecedented impact of the ongoing covid-19 pandemic has created a significant impact on the stereotactic planning software market due to a shortage of inpatient footfalls in hospitals and other centers.

Preference now is being given to the treatment of COVID-19 patients, thus halting product launches for stereotactic planning. Also, this has led to the postponement of the enrolment of the new participants is such studies. Now, with the availability and commencement of the COVID-19 vaccination, the research activities expected to resume in the near future.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6452

Key Takeaways from Stereotactic Planning Software Spending Analysis Market Study

  • Integrated stereotactic planning solutions are expected to grow 2x by 2031 as compared to 2021 owing to ease of use and higher adoption rates.
  • CT scans are projected to capture over 46% of the global market by 2031. This is attributed to inherent accuracy in identifying and localizing intracranial lesions.
  • North America is the largest revenue-generating region for stereotactic planning software, with the U.S. accounting for over 79% of the regional market.
  • The U.K. holds the lead in Europe, accounting for over 37% of the region through the end of 2031.
  • East Asia is poised to grow at the highest CAGR of 5.3% during the forecast period with China accounting for over 62% of the market owing to the large subclinical patient pool of patients.

Growing cases of neurological disorders, small cell lung cancer, and prostate cancer, along with an increase in patient awareness and screening, favorable reimbursement scenarios, approvals, and grants for product development are factors influencing market growth. The implementation of artificial intelligence, the use of visual improvements in real-time are some of the upcoming trends that are expected to create growth opportunities for manufacturers through the assessment period,” says the FMI Analyst

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6452

Who is Winning?Some of the leading companies operating in the stereotactic planning software spending analysis market are focusing on collaborations and mergers and acquisitions for global expansion options with a focus on emerging economies. Thus, enhancing their market presence. For instance,

  • In March 2021, RaySearch Laboratories AB (publ) announced a sales agent agreement with Canon Medical Systems USA, Inc., enabling RaySearch America’s salesforce to promote Canon Medical’s Aquilion Large Bore CT and Celesteion PET/CT products.
  • In March 2021, Brainlab announced the acquisition of Mint Medical GmbH. The acquisition aims to improve the structured diagnosis, analysis, and treatment of cancer and other diseases to address the demands of modern medicine and personalized treatments.

The key market players covered by FMI include Brainlab, Inc., Renishaw Inc., Inomed Inc., RaySearch Americas, Inc., Mevis Informática Médica, FHC, Inc., Integra LifeSciences Corporation, Elekta Solutions AB, and SurgiFRONT Ltd.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global Stereotactic Planning Software Spending Analysis is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on Stereotactic Planning Software Spending Analysis based on solution type (Stand-alone Stereotactic Planning Solution, Integrated Stereotactic Planning Solution, Services), imaging modality (CT Images, MR Images, Angiographic Images), and end-user (hospitals, ambulatory surgical centers, cancer research institutes) across seven major regions.

Stereotactic Planning Software Spending Analysis by CategoryBy Solution Type:

  • Stand-alone Stereotactic Planning Solution
  • Integrated Stereotactic Planning Solution
  • Services
    • Consulting & Implementation
    • Training Services
    • On-demand Support Services

By Imaging Modality:

  • CT Images
  • MR Images
  • Angiographic Images

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6452

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Pharmaceutical Caps and Closures Market to surpass US$ 2.27 Billion in valuation by the end of 2021

According to Future Market Insights (FMI), the demand for pharmaceutical caps and closures is expected to rise considerably, enabling the market to surpass US$ 2.27 Bn in valuation by the end of 2021.

Continuous advancements in research and development for drug supplements is a key factor speeding up packaging innovations. Advanced technologies used in packaging primarily focus on ensuring stability of drugs during storage, shipment, and delivery.

In the coming years, the rising cases of chronic disease will support the expansion of the market. The role of smart packaging for medication is increasing to offer greater precision of administered medication, which directly affects patient compliance. This will influence the adoption of cost-effective yet advanced packaging solutions among manufacturers.

The pharmaceutical caps and closures market will therefore register adoption of digital manufacturing. This technology offers high quality caps and closure, with minimal time and cost requirements.

Focus on reducing product damage by user has encouraged inventors to introduce multi-dose delivery caps. The product’s user can remove fluid from the vial by interfacing a needle to the cap. The smart cap ensures that leftover fluid is clean.

In the past few years, environmental awareness among consumers has increased the need for sustainable packaging. In pharmaceutical packaging, the primary concern is product stability.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13237

The demand for reducing the risk of cross contamination of product drives the use of biodegradable material in caps and closures. Also, waste product management is a key concern. Environmentally-friendly material produce lesser waste and are also recyclable.

Despite this, plastics remain the preferred material for manufacturing caps and closures. Plastic use in the market is expected to rise at 6.4% as producers aim for greater flexibility.

Key Takeaways from Pharmaceutical caps and closures Services Market Study

  • Despite restricted growth amid COVID-19, the demand for pharmaceutical caps and closures is expected to rise at nearly 5% CAGR in 2021.
  • Increasing focus on light weight packaging is driving a transition towards resin-based packaging material.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 26% and 17% of the Europe market respectively in 2021
  • The U.S. will account for a dominant share of 89% in the North America market through the forecast period.
  • China is the largest and fastest growing market in East Asia, exhibiting 8% CAGR through 2031.

“Increasing demand for smart and safe packaging solutions for pharmaceuticals, besides favorable reimbursement policies will offer lucrative growth opportunities for pharmaceutical caps and closure manufacturers through the assessment period in 2031,” says the FMI analyst.

Increase in Funding for Research Activities Offers Growth OpportunitiesLeading manufacturers in the pharmaceutical caps and closures market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical packaging products.

For instance, Voltaren “No Mess” applicator from GSK Consumer Health was co-developed with Neopac and Nypro Healthcare.

Big drug producers are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13237

Who is winning?The global market is set to expand due to the rising prevalence of chronic diseases. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

Some of the leading players in the pharmaceutical caps and closures market include but are not limited to Berry Global Inc., Amcor Plc, Aptar Inc., Closure Systems International Inc., O.Berk Company LLC, Bericap GmbH and Co KG, UNITED CAPS, CL Smith Company, Georg MENSHEN GmbH & Co. KG, WestRock Company, West Pharmaceutical Services Inc., Drug Plastics and Glass Co Inc., Gerresheimer AG, DWK Life Sciences GmbH, Parekhplast India Limited, and Parshva Exim Limited.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global pharmaceutical caps and closures market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the pharmaceutical caps and closures treatment market on basis of the main indication in detail, cover every aspect of the market such as product type, molecule type, application, and service provider across seven major regions.

Phramacutical caps and Closures Services Market by CategoryProduct type

  • Screw Caps & Closure
  • Snap Caps & Closure
  • Push-Pull Caps & Closure
  • Stopper & Seals
  • Others

Functionality

  • Child Resistant
  • Tamper-evident

Material type

  • Plastic
  • Elastomer
  • Metal

Avalability

  • Prescription (Rx) Pharmaceuticals
  • “Over-the-Counter (OTC) Pharmaceuticals”

Drug Modality

  • Small Molecule (Synthetic Drugs)
  • Biopharmaceuticals

Therapeutic class

  • Anticancer Drugs
  • Anti-infective Drugs
  • Anti-viral Drugs
  • Anti-bacterial Drugs
  • Anti-fungal Drugs
  • Others
  • Cardiovascular Drugs
  • Anti-inflammatory Drugs
  • Analgesics Drugs
  • Anti-diabetics
  • Ophthalmic Drugs
  • Neurological Drugs
  • Others

End Users

  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing  Organizations (CMO)
  • Contract Research Organizations (CRO)
  • Academic & Research Institutes

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13237

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Quadriplegia Treatment Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

Quadriplegia Treatment Market Overview

According to the latest research by Future Market Insights, quadriplegia treatment market is expected to grow at a CAGR of 4.1% during the forecast period. The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities in the near future.

What are the key Drivers of Quadriplegia Treatment Market?

Quadriplegia is caused by spinal cord injury which is caused due to trauma at the base of the neck or skull. Some of the common causes of quadriplegia, otherwise known as tetraplegia are paralysis after any accident, tumors of the spinal cord or other spinal cord diseases. The injury to the spinal cord may cause partial or total limb paralysis.

According to 2020 data sheet of Spinal Cord Injury Statistics, it was estimated that approximately 17,810 new cases of spinal cord injuries occur every year in the U.S. Some of the reasons for quadriplegia include stroke, vehicular accidents, falls, violence, sports, medical or surgical causes and others.

According to WHO statistics, published in June 2021, 20-50 million people suffer from road traffic accidents every year which lead to non-fatal injuries yet permanent disabilities to them. With the increasing rate of road traffic accidents, the demand for quadriplegia treatment is set to show a positive growth over the forecast period.

Recent technological advancements and various R&D activities in the field of quadriplegia treatment are one of the leading causes which will boost the demand for this market in forthcoming years. There is an increased level of awareness amongst the patients suffering from spinal cord injuries about various treatment options available to improve their quality of life. This is another factor which will propel the demand for various treatments for quadriplegia during the forecast market.

Electrical Stimulation: Revolutionary Technique that Got Quadriplegic People Back on their Feet.

Electrical stimulators which were originally designed to treat chronic pain helped more than a dozen patients with quadriplegia to wiggle their toes, flex their legs or even walk with support.

This was a revolutionary technique which was conducted in the lab of University of Louisville in Kentucky. Electrical stimulation thus made promising and huge gains for people with paralysis wanting to regain their functionalities. The study was published in July 2019, after which thousands of patients have enrolled in the wait lists for the electrical stimulation technique.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-14232

U.S. and Canada Quadriplegia Treatment: Regional Outlook

U.S. and Canada region was found to be the largest market for the diagnosis and treatment of spinal cord injury (SCI). Increasing awareness and advanced technologies are the main drivers of this market. Most of the accidents found that alcohol was one of the most important factors; that is, approximately 25% of spinal cord injuries.

In the United States, the average annual medical cost for treating an acute spinal cord injury has been found to be in the range of $ 15,000 to $ 30,000 per year. All these factors are expected to drive the market growth of quadriplegia treatment market and offer lucrative opportunities for the providers.

Europe Quadriplegia Treatment: Regional Outlook

Europe was observed to be the second largest market, region wise for the quadriplegia treatment industry. Some of the factors contributing to this large market share are the presence of leading research institutes in the region for various neurological disease diagnosis and treatment. Increased awareness regarding various new technologies which help the quadriplegic patients lead a relatively normal life is also another key driver for this industry in Europe.

Who are the key player of Quadriplegia Treatment Market?

Major manufacturers of medications needed to treat quadriplegia are

  • Merck & Co.
  • Sanofi Pharmaceuticals
  • Baxter International
  • Zydus Cadila
  • GlaxoSmithKline
  • AstraZeneca
  • Cipla
  • Johnson & Johnson
  • Bristol Myers Squibb Co.
  • Eli Lily & Co.
  • Teva Pharmaceuticals
  • Takeda Pharmaceutical Co Ltd
  • Hoffmann La Roche
  • Sun Pharmaceuticals.

In November 2020, Pfizer and Mylan announced the merger of Pfizer’s Upjohn generics unit and Mylan. This deal was a part of restructuring drive at Pfizer, which was aimed for stronger foothold in the innovative medicines division of the company.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Quadriplegia Treatment Market Report Highlights:

  • Shifting Industry dynamics.
  • In-depth market segmentation.
  • Historical, current and projected industry size recent industry trends.
  • Key Competition landscape.
  • Strategies for key players and product offerings.
  • Potential and niche segments/regions exhibiting promising growth.
  • A neutral perspective towards market performance.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key Segments

By Treatment Type:

  • Corticosteroids
  • Non- Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Antidepressants
    • Selective serotonin reuptake inhibitors (SSRIs)
    • Serotonin and norepinephrine reuptake inhibitors (SNRIs)
  • Anticonvulsants
  • Narcotic Analgesics
  • Antispasmodics & Muscle Relaxants
  • Antibiotics

By Route of Administration:

  • Oral
  • Intravenous
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores?

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA
  • PRE BOOK @ https://www.futuremarketinsights.com/checkout/14232

Urinary Bag Market is projected to expand at a CAGR of 4.4% over 2021-2031.

According to a revised report published by Future Market Insight (FMI), the global urinary bag market was valued at US$ 1.74 Bn in 2021, and is predicted to expand at a CAGR of 4% over the forecast period (2021–2031).

Urinary bags are primarily used to help in the collection of urine from the bladder, which is attached to the other end of a catheter. These are used by patients suffering from urinary incontinence, retention issues, or spinal cord injuries that made a urinary catheter necessary. Urinary bags are available in leg bag, belly bag, large capacity bag, and drainage bag variants.

Leg bags are small sized products designed to be worn under clothes. It is designed for active people with urinary incontinence problems. The product is worn around the waist. Availability in various designs to suit specific requirement of patients has been creating growth opportunities for the market.

Consolidation activities such as collaborations, partnerships, patent transfers, and increasing research and development activities, are distinctive trends influencing competition in the urinary bags market. The growing prevalence of urinary incontinence and gynaecology surgeries is a major factor leading to an increase in the demand for urinary bags, globally.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13236

Key Takeaways from Urinary Bag Market Study

  • Drainage bags are expected to hold dominance with a market share of more than 49% in 2021. Rising applications in hospitals among geriatrics and post-surgery patients will aid expansion of sales within this category.
  • Urinary bags with a 1000 ml capacity are expected to account for 33% the global market share by 2031.
  • Hospitals are expected to account for 38% of the market share in 2031 which can be broadly attributed to the higher footfall of patients they register on a daily basis.
  • The U.S. has emerged as a leading market, accounting for over 90% of sales registered in North America.
  • Germany is a leading market for urinary bags and is forecast to account for over 33% of sales in Europe in 2021.
  • The market in Japan is projected to emerge dominant East Asia, driven by the presence of a mature healthcare sector and easier access to new technologies.

“The global urinary bags market is expected to witness significant growth in the near future driven by expanding global geriatric population, healthcare investments, and a focus on customized products to meet individual patient needs. Market players are therefore likelier to focus on research initiatives to offer advanced technologies for better comfort and lowering the risk of infection” says an analyst of Future Market Insights.

Government Initiatives Towards Urinary Bag UsageIntegration of advanced features and technology that aid in patient care has strengthened support and services to patients. The COVID-19 crisis drastically increased the demand for urinary bags owing to the massive impact of the disease on the global healthcare system.

This has generated massive growth potential for the urinary bag market for treatments and patient-care. Governmental support for ongoing clinical research and the usage of urinary bags in hospitalization processes, have created a conductive environment for market players.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13236

Who is Winning?Leading players in the moderately fragmented urinary bags market are focused on investments into research and development for product development objectives. In addition to portfolio expansion, manufacturers are also seeking to consolidate their position with strategic geographical expansion endeavours.

Some of the leading players in the urinary bags market include but are not limited to C.R. Bard Inc., Medline Industries, Inc., Cardinal Health, Inc., Hollister Incorporated, Teleflex Incorporated, Cook Medical, Moore Medical Llc., Mckesson Medical-Surgical Inc., Arcus Medical Llc., Urocare, Covidien, Coloplast A/S, B. Braun, Romsons, Poly Medicure Limited, G.Surgiwear Ltd., Kiefel Medical, Jolfamar, UROMED, Wujiang Evergreen Ex/Im Co. Ltd., Leboo Healthcare Products Limited.

What Does the Report Cover?Future Market Insights offers a unique perspective and actionable insights on the urinary bag market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2021 – 2031. The research study is based on product type (Leg Bag, Belly Bags, Large Capacity Bags, Drainage Bags), capacity (Less than 500 ml, 500 ml, 1000 ml, 2000 ml, 4000 ml), usage (Reusable Urinary Bags, Disposable Urinary Bags), patient age (Paediatric, Adult) and end users (Hospitals, Clinics, Ambulatory Surgical Centers, Long Term Care Centers, Home Care Settings) across seven key regions of the world.

Market by CategoryProduct

  • Leg Bag
  • Belly Bags
  • Large Capacity Bags
  • Drainage Bags

Capacity

  • Less than 500 ml
  • 500 ml
  • 1000 ml
  • 2000 ml
  • 4000 ml

Usage

  • Reusable Urinary Bags
  • Disposable Urinary Bags

Patient Age

  • Pediatric
  • Adult

End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Long Term Care Centers
  • Home Care Settings

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13236

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA